Mounjaro, FDA-approved for diabetes), and liraglutide (Saxenda)
These medications exhibit different dosing recommendations, trial data, and FDA copies of labeling
How to build a list : Offer a lead magnet: Free Guide: 10 Questions to Ask Your Doctor About GLP-1 Medications in exchange for email signup Pop-up on your website: Get weight-loss tips from a psychiatristjoin 500+ subscribers Capture emails from initial inquiries (with permission) What to send : Welcome sequence (3-5 emails): Introduce yourself, share your approach, address common concerns, make booking easy Weekly or biweekly newsletter: Quick tips, answer one FAQ, share a recent blog post, patient success snippet Re-engagement campaign: For people who inquired but didnt bookStill considering weight-loss treatment
Eli Lilly, the maker of Mounjaro and Zepbound, is urging the court to impose stricter diagnostic proof requirements in the ongoing GLP-1 gastroparesis litigation
Wells Fargo red sign displayed on a city building exterior